$1.55M Raised for Plan A™ Male Birth Control Product, Seeking Clinical Trials in 2023

LOS ANGELES, June 2, 2023 /PRNewswire/ — After years in development by the Parsemus Foundation, NEXT Life Sciences, Inc. has announced its plans to bring a new contraceptive product to market through Plan A™ – a safe, effective, reversible birth control for men. “In developing Plan A™, NEXT has seen increasing demand for male contraception … Read more